See also this year's filing and all EDGAR filings for this company.
PDF Report 0001302573_2017_OncoMed_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001302573')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001302573, OncoMed Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 189,583,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,471,000 |
| 3 | remainder_Assets | 1,428,000 |
| 4 | LiabilitiesCurrent | 55,853,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 162,657,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,827,000 |
| 9 | ResearchAndDevelopmentExpense | 109,713,000 |
| 10 | remainder_Expenses | 14,000 |
| 11 | remainder_Revenues | 25,153,000 |
| 12 | remainder_NetIncome | 299,000 |
| 13 | remainder_ComprehensiveNetIncome | 240,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 195,482,000 |
| 1 | Liabilities | 218,510,000 |
| 2 | Expenses | 128,554,000 |
| 3 | Revenues | 25,153,000 |
| 4 | StockholdersEquity | -23,028,000 |
| 5 | NetIncome | -103,102,000 |
| 6 | ComprehensiveNetIncome | -102,982,000 |
| 7 | BaseVar | 284,119,000 |
| 8 | EconomicCapitalRatio | -0.689 |
Edgar->Model Mapping
Feature Distribution
